Popular Articles

Data Ranks Insurers According To Speed Of Claim Payment, Share Of Denials
Aetna, Cigna and Humana ranked highest nationally on criteria including speed of health claim payments and fewest claims denied, according to the 2009 PayerView Rankings, the Boston Globe reports. The rankings -- prepared by Athenahealth in collaboration with Physicians Practice management journal -- evaluated 172 national, regional and government payers in 40 states.According to the data, insurers paid physicians an average 5.3% faster in 2008 and denied an average of 9% fewer medical claims compared with 2007 figures. On average, national health insurers paid physicians in 33 days and denied 9.2% of claims.According to the Globe, the rankings reveal some of the obstacles that can result from the complexities and bureaucracy involved in the medical billing process, with each insurer operating in different ways. Jonathan Bush, chair and CEO of Athenahealth, said, "This is the biggest problem we have in health care -- the inability to close supply chains and to practically and tactically connect doctors with payers and patients," adding, "These connections are broken" (Weisman, Boston Globe, 5/28).
generic viagra online
NIH Announces Final Guidelines For Federally Funded Embryonic Stem Cell Research
NIH on Monday announced final guidelines for assessing whether newly created embryonic stem cell lines can be used for federally funded research, as well as clarifying how old lines will be evaluated, CongressDaily reports (CongressDaily, 7/7). In March, President Obama overturned former President George W. Bush"s policy limiting federal funding of embryonic stem cell research to 21 lines. Obama asked NIH to develop new guidelines that would govern such research going forward. The agency received about 49,000 comments on a draft version of the guidelines announced in April (Vergano, USA Today, 7/7). The final guidelines, which take effect on Tuesday, state that stem cell lines used in federally funded research must come from embryos discarded after in vitro fertilization procedures. In addition, donors must have been informed that the embryo would be destroyed for stem cell research and made fully aware of other options, which include donating the embryo to other individuals for use in infertility treatments. Lastly, donors cannot be paid for an embryo, and no threats or other inducement can be part of the decision to donate (Vedantam, Washington Post, 7/7).Raynard Kington, acting director of NIH, said that lines developed before Tuesday likely would be approved if they were created in the spirit of the new rules, even if they do not follow them to the letter (Harris, New York Times, 7/7). NIH"s Advisory Committee to the Director will review such lines on a case-by-case basis. NIH also will create a registry of qualifying stem cell lines for use by researchers (Los Angeles Times, 7/7). Kington said, "Many of the lines already in existence may have met very rigorous standards of informed consent but may have been implemented in ways not consistent with the present guidelines." He added, "It"s unreasonable to retroactively apply procedures intended for future use" (New York Times, 7/7). Kington also said of the new guidelines, "We think this is a reasonable compromise to achieve the president"s goal of both advancing science while maintaining rigorous ethical standards. We believe that judgment is necessary" (Los Angeles Times, 7/7). Broadcast CoverageNPR"s "Morning Edition" on Tuesday reported on the stem cell guidelines (Shapiro, "Morning Edition," NPR, 7/7).
News of the day
New Harmonised SmPCs For 'Cozaar'(R) And 'Cozaar'(R)-Comp Implemented In The U.K. Following European Commission Decision
Merck Sharp & Dohme Limited (MSD) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has implemented the harmonised Summary of Product Characteristics (SmPCs) for "Cozaar"® (losartan potassium) and "Cozaar"®-Comp (losartan potassium/ hydrochlorothiazide) into the U.K. Marketing Authorisation following a European Commission (EC) Decision.
Diagnostics

University Of Queesnland's Speech Pathology Students Teach The Art Of Smooth Talking, Australia

A group of UQ speech pathology students recently ran an intensive treatment program for people who stutter. Coordinated by lecturer Dr Elizabeth Cardell, the five-day program, held between July 20-24, required participants to visit the on-campus clinic for nine-hour sessions, and participate in both individual and group treatment exercises. "Results of research indicate that for most adults who stutter, intensive practice of a different and smoother speech pattern is the most effective way to change stuttered speech," Dr Cardell said. "Additionally, people can make a lot of change very quickly and this can be reassuring and very motivating." "Given that one to two percent of the adult population stutters, we need more graduates with these competencies in stuttering management to address a communication disorder that can have debilitating effects on people educationally, vocationally, and socially." For some years now, there have been no professionally run intensive treatment programs in Queensland for people who stutter. Dr Cardell said the UQ program - which is a replication of a well-researched program at La Trobe University in Melbourne - would provide an opportunity for Queenslanders to participate in evidence-based best practice treatment for stuttering. "The UQ clinic is dedicated to ensuring the community can obtain excellent treatment services for stuttering while simultaneously ensuring speech pathology students can experience working with specialist staff whilst learning to deliver the treatment," she said. In addition to the five-day intensive program, participants will be required to attend seven follow-up sessions. The program can be tailored to the "talking needs" of each person, with speech exercises designed to help with talking on the telephone, shopping, making inquiries and speaking in front of an audience. Dr Cardell said the exact cause of stuttering was unclear. "There is research that shows structural and functional differences in the brains of people who stutter, however, whether this is the cause of stuttering or the result of stuttering is not certain," she said. "We believe that stuttering is a problem of coordinating the timing of speech. "We know that stuttering is not caused by poor parenting habits or extreme anxiety, although people who stutter may become very anxious as a result of their trouble talking." It has been proposed that the program be run twice per year at UQ. "Stuttering is an extremely frustrating and debilitating condition that can severely limit participation and opportunities in daily communication," Dr Cardell said. "Also, it can negatively impact on quality of life. "Queenslanders deserve access to the best available treatments and the Division of Speech Pathology at UQ is delighted to offer this opportunity." University of Queesnland


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):